Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-19-001597
Filing Date
2019-07-29
Accepted
2019-07-29 16:33:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 rocksprings-acrs071919.htm SC 13G 107620
  Complete submission text file 0001172661-19-001597.txt   109136
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89137 | Film No.: 19981585
SIC: 2834 Pharmaceutical Preparations

Mailing Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202
Business Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202 4102200129
Rock Springs Capital Management LP (Filed by) CIK: 0001595725 (see all company filings)

EIN.: 800944416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G